Status:
RECRUITING
Electronic Physician Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: The DETECT AS Trial
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Edwards Lifesciences
Conditions:
Aortic Stenosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The DETECT AS Trial is a randomized clinical trial and quality improvement initiative that seeks to investigate the impact of electronic provider notification of severe aortic stenosis (AS) on its man...
Eligibility Criteria
Inclusion
- Subjects with severe aortic stenosis having an aortic valve area of less than or equal to 1.0cm2.
Exclusion
- Subjects with bioprosthetic or mechanical valves in the aortic position
Key Trial Info
Start Date :
February 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 15 2026
Estimated Enrollment :
940 Patients enrolled
Trial Details
Trial ID
NCT05230225
Start Date
February 9 2022
End Date
February 15 2026
Last Update
April 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114